MEMOTEXT provides secure, data-driven digital engagement solutions that boost treatment adherence, simplify care coordination, and maximize outcomes, all while delivering measurable ROI for health systems. Build your own solution or choose from our co-created marketplace.
Not sure where to start? Chat with our MTxPERT! By using this tool, you acknowledge that you have read and understand our disclaimers.
MEMOTEXT is a platform for co-creation of digital patient engagement programs and therapeutics. We use health data to identify risk and drive personalization of secure, omni-channel treatment adherence, care-coordination and patient support applications.
Provide personalized and secure interactive digital engagement through SMS, web, mobile, voice assistants and more.
Predictive and advanced analytics for identification of at-risk populations and evidence-informed tailoring of communications content.
Empathy-based and evidence-driven expertise in adherence, care-coordination, patient support and readmission reductions through
Connections to help manage your flow of data with integrations to digital health trackers, research portals and resource banks.
Who are you trying to target?
Who is in need?
What are the results you want to achieve?
How do you want to deliver your intervention?
Why are we seeing the current results and when should we take action?
MEMOTEXT is a platform for co-creation of digital patient engagement programs and therapeutics. We use health data to identify risk and drive personalization of secure, omni-channel treatment adherence, care-coordination and patient support applications.
A4i is our digital application and clinical portal for SMI such as schizophrenia, psychosis and OUD. A4i has been implemented in Canada and US sites.
71%
engagement and improvements in depression, psychoticism, and other symptom domains at CAMH
$4,000
savings per patient per day from 10% hospital diversion at Riverside.
2+ hours
saved per month in the clinical outreach team at McKesson Canada and SE Health
40,000
daily interactions freed up time for care coordinators to maintain quality of service
30,000+
pregnant mothers who have completed or are currently going through our maternal health SMS program.
5+
health units adopted our maternal SMS messaging program
31.4%
medication adherence improvements in a randomized control study with Johns Hopkins University
87.5%
retention rate for “HealthNHand” designed to send daily messaging to support the health of asthma patients with PerformRx
